Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interstitial lung diseases
Marlies Wijsenbeek, Atsushi Suzuki, Toby M. Maher
The Lancet (2022) Vol. 400, Iss. 10354, pp. 769-786
Closed Access | Times Cited: 262

Showing 1-25 of 262 citing articles:

Idiopathic pulmonary fibrosis: state of the art for 2023
Anna J. Podolanczuk, Carey C. Thomson, Martine Rémy‐Jardin, et al.
European Respiratory Journal (2023) Vol. 61, Iss. 4, pp. 2200957-2200957
Closed Access | Times Cited: 160
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies
Isabella Lurje, Nadine T. Gaisa, Ralf Weiskirchen, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101191-101191
Closed Access | Times Cited: 69
Pulmonary fibrosis: from pathogenesis to clinical decision-making
Thomas Koudstaal, Manuela Funke-Chambour, Michael Kreuter, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1076-1087
Closed Access | Times Cited: 67
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis
Wolfgang Merkt, Merle Freitag, Maren Claus, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 4, pp. 543-546
Open Access | Times Cited: 61
Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment
Malik Althobiani, Anne‐Marie Russell, Joseph Jacob, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 22
The bronchoalveolar lavage fluid CD44 as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases
Magda Suchánková, Eszter Zsemlye, Ján Urban, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease
Riya Thapa, Arockia Babu Marianesan, Arcot Rekha, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Open Access | Times Cited: 2
Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
Jung Yoon Pyo, Lucy Eunju Lee, Yong‐Beom Park, et al.
Yonsei Medical Journal (2022) Vol. 64, Iss. 1, pp. 11-11
Open Access | Times Cited: 47
Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers
Giuliana Cerro Chiang, Tanyalak Parimon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2405-2405
Open Access | Times Cited: 31
Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases
Kentaro Hata, Toyoshi Yanagihara, Keisuke Matsubara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults
Ayodeji Adegunsoye, Elizabeth Freiheit, Emily White, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232427-e232427
Open Access | Times Cited: 28
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021
Tingting Jiang, Hui Su, Jing Xu, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 12
The mechanism of gut-lung axis in pulmonary fibrosis
Yawei Dong, Lanlan He, Zhongbo Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
A Lung CT Foundation Model Facilitating Disease Diagnosis and Medical Imaging
Zebin Gao, Guoxun Zhang, Hengrui Liang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases
Giulia Morina, Domenico Sambataro, Alessandro Libra, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 275-275
Open Access | Times Cited: 1
Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy
Naths Grazia Sukubo, Paolo Bigini, Annalisa Morelli
Beilstein Journal of Nanotechnology (2025) Vol. 16, pp. 97-118
Open Access | Times Cited: 1
Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD): Back to the Future
Giordano Fiorentù, Nicol Bernardinello, G. Giulianelli, et al.
Advances in Therapy (2025)
Open Access | Times Cited: 1
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Florian Rieder, Laura E. Nagy, Toby M. Maher, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
Ruyan Wan, Lan Wang, Miaomiao Zhu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16410-16410
Open Access | Times Cited: 19
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Yerin Kim, Hyung-In Yang, Kyoung Soo Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14509-14509
Open Access | Times Cited: 17
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Vasiliki Liakouli, Antonio Ciancio, Francesco Del Galdo, et al.
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 21-32
Closed Access | Times Cited: 17
Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges
Yixiang Hu, Ying Huang, Lijuan Zong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top